Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

BACKGROUND: Imatinib mesylate is an effective treatment for metastatic gastrointestinal stromal tumor (GIST). However, most patients eventually develop resistance and there are few other treatment options. Immunotherapy using genetically modified or designer T cells (dTc) has gained increased attent...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Katz, Steven C, Burga, Rachel A, Naheed, Seema, Licata, Lauren A, Thorn, Mitchell, Osgood, Doreen, Nguyen, Cang T, Espat, N Joseph, Fletcher, Jonathan A, Junghans, Richard P
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599052/
https://ncbi.nlm.nih.gov/pubmed/23433424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-46
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires